DEEP BIO
Deep Bio is a medical AI startup that aims to revolutionize cancer diagnosis. Deep Bio combines cutting-edge AI algorithms with digital pathology to empower pathologists and streamline existing workflows.
DEEP BIO
Industry:
Artificial Intelligence Biotechnology Health Diagnostics Medical Software
Founded:
2015-10-08
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.deepbio.co.kr
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Apache Mobile Non Scaleable Content Euro Amazon Google Apps For Business PHP
Current Employees Featured
Founder
Official Site Inspections
http://www.deepbio.co.kr Semrush global rank: 6.12 M Semrush visits lastest month: 1.32 K
- Host name: ec2-13-125-156-192.ap-northeast-2.compute.amazonaws.com
- IP address: 13.125.156.192
- Location: Incheon South Korea
- Latitude: 37.4562
- Longitude: 126.7288
- Timezone: Asia/Seoul
- Postal: 21539
More informations about "Deep Bio"
About โ Deep Bio
Deep Bio was founded with the transformative mission: To advance patient outcomes by driving innovation in technology, while empowering clinicians by providing the tools to make critical โฆSee details»
Deep Bio - Crunchbase Company Profile & Funding
Headquarters Regions Asia-Pacific (APAC) Founded Date Oct 8, 2015 Founders Sun Woo Kim Operating Status Active Last Funding Type Corporate Round โฆSee details»
Deep Bio Company Profile | Management and Employees List
Find contact information for Deep Bio. Learn about their Research & Development, Business Services market share, competitors, and Deep Bio's email format.See details»
DeepBio - 2025 Company Profile & Team - Tracxn
DeepBio is a seed company based in Seoul (South Korea), founded in 2015 by Sun Woo Kim. It operates as a Developer of image analysis platform for prostate cancer diagnosis. DeepBio โฆSee details»
Deep Bio Inc. Company Profile | Seoul, Seoul, Republic Of Korea ...
Find company research, competitor information, contact details & financial data for Deep Bio Inc. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
Deep Bio Inc. Company Overview, Contact Details & Competitors
Sep 9, 2024 Deep Bio Inc. 's main headquarters is located at Guro-gu 27 Digital-ro 33-gil 609-613 Seoul, Seoul 08380 KR. The company has employees across 1 continents, including โฆSee details»
Deep Bio - Overview, News & Similar companies | ZoomInfo.com
Feb 1, 2024 View Deep Bio (www.deepbio.co.kr) location in South Korea , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Deep Bio (South Korea) Funding: $17.9M - Medical Startups
Jun 25, 2025 Deep Bio combines cutting-edge AI algorithms with digital pathology to revolutionize cancer diagnosis. Deep Bio develops AI prostate cancer diagnosis support...See details»
Deep Bio Inc. | LinkedIn
Deep Bio Inc. is a pioneering AI-driven healthcare company revolutionizing cancer pathology. With cutting-edge deep learning technologies, we develop advanced In Vitro Diagnostic Software as Medical Devices (IVD SaMDs) that โฆSee details»
Deep Bio Earns Coveted Spot in Korea AI Startup 100 List for the โฆ
Oct 9, 2023 Deep Bio consistently shares its innovative research findings through publication in renowned medical journals, including Cancers and npj Digital Medicine. For more information, โฆSee details»
Deep Bio Selected as โKorea AI Startup 100โ for Two Consecutive โฆ
Oct 21, 2022 To learn more, visit www.deepbio.co.kr. DeepDx® Prostate is a clinically-validated AI for prostate core needle biopsy tissue image analysis. Whole-slide images (WSIs) of H&E โฆSee details»
DeepBio becomes first Korean cancer diagnostic A.I. company to โฆ
Nov 20, 2023 DeepBio won the Innovation Award in the Digital Healthcare category, the first time the A.I. diagnostic-aid software company helped detect meaningful findings among โฆSee details»
Deep Bio Korea AI Startup 100 List | Tissuepathology.com
Oct 5, 2023 Deep Bio consistently shares its innovative research findings through publication in renowned medical journals, including Cancers and npj Digital Medicine. For more information, โฆSee details»
Deep Bio
DeepBio, 'prostate cancer' detection using AI ..closes seed rounding Deep Bio, is a start-up company that develops artificial intelligence (AI) to diagnose prostate cancer.See details»
Deep Bio Super Gap Startup 1000+ | Tissuepathology.com
Aug 7, 2023 SEOUL, SOUTH KOREA (PRWEB) JULY 07, 2023 โ Deep Bio Inc., a leader in artificial intelligence (AI)-powered cancer diagnostics, has been selected for the South Korean โฆSee details»
Deep Bio Secures Spot in South Korean Governmentโs Prestigious โฆ
An award ceremony was held on July 4th, where Director Byeonggweon Lee from the Korean Ministry of SMEs and Startups (MSS) presented a plaque and expressed confidence in Deep โฆSee details»
DeepBio Wins The CES Innovation Award For Pioneering, A New โฆ
Nov 27, 2023 The Consumer Technology Association (CTA) announced the products and technologies that won CES Innovation Awards. DeepBio won the Innovation Award in the โฆSee details»
StartUp_ (์ฃผ)๋ฅ๋ฐ์ด์ค - NextRound
๋ํ ์ ํ์ธ DeepDx® Prostate๋ H&E ์ผ์๋ ์ ๋ฆฝ์ ์นจ์๊ฒ ์ฌ๋ผ์ด๋ ๋์งํธ ์ด๋ฏธ์ง๋ฅผ ๋ถ์ํด ์ ์์ญ์ ์ฐพ๊ณ , ์ค์ฆ๋๋ฅผ ๋ถ์ํฉ๋๋ค. ์์ ์ค์ฆ๋๋ฅผ ๊ตฌ๋ถํ๋ ๊ธ๋ฆฌ์จ ํจํด overlay ์์ฑ์ ๋ฌผ๋ก , ๊ฐ โฆSee details»
DeepBio cancer AI CES Innovation Award | Tissuepathology.com
Nov 29, 2023 DeepBio announced it has been awarded the CES Innovation Award as the first Korean cancer diagnosis AI company in CES 2024 to be held in the upcoming January.See details»
Products โ Deep Bio
An Al model that performs segmentation and whole-slide scoring to provide measurements of ER receptor status in breast cancer. This algorithm allows pathologists to quickly and accurately โฆSee details»